These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 426001)

  • 41. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.
    Preisler HD; Raza A; Barcos M; Azarnia N; Larson R; Walker I; Browman M; Grunwald H; D'Arrigo P; Doeblin T
    J Clin Oncol; 1987 Jan; 5(1):75-82. PubMed ID: 3806162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of colony-stimulating and colony-forming cells in peripheral blood in acute non-lymphoblastic leukemia.
    Hörnsten P; Granström M; Wahren B; Gahrton G
    Acta Med Scand; 1977; 201(5):405-10. PubMed ID: 302633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of refractory adult acute lymphocytic leukaemia and acute undifferentiated leukaemia with an anthracycline antibiotic and cytosine arabinoside.
    Early AP; Preisler HD; Gottlieb AJ; Lanchant NA
    Br J Haematol; 1981 Jul; 48(3):369-75. PubMed ID: 7259987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Small-dose cytosine arabinoside in the treatment of elderly patients with acute leukemia and refractory anemia with excess of blast.
    Satou Y; Kubota T; Yonekura S; Noguchi K; Oobayashi Y; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Oct; 11(4):249-54. PubMed ID: 3617109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
    Hirano M; Uetani T; Morita A; Sako F; Koie K
    Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692
    [No Abstract]   [Full Text] [Related]  

  • 46. Prediction of the response of patients with acute nonlymphocytic leukemia to cytosine arabinoside (NSC-63878) therapy.
    Burns CP; Armentrout SA; Stjernholm RL
    Cancer Chemother Rep; 1972 Aug; 56(4):527-34. PubMed ID: 4507687
    [No Abstract]   [Full Text] [Related]  

  • 47. Combination chemotherapy with cytosine arabinoside and rubidomycin in 30 cases of acute granulocytic leukemia.
    Gluckman E; Basch A; Varet B; Dreyfus B
    Cancer; 1973 Mar; 31(3):487-91. PubMed ID: 4511906
    [No Abstract]   [Full Text] [Related]  

  • 48. Relationship between in vitro colony-forming ability and expression of Ia-like antigen of acute nonlymphocytic leukemia (ANLL) cells.
    Hiraoka A; Yamagishi M; Ohkubo T; Yoshida Y; Uchino H
    Blood; 1980 Nov; 56(5):859-65. PubMed ID: 6932979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of clonogenic assay for induction and duration of complete remission in acute myelogenous leukemia.
    Marie JP; Zittoun R; Delmer A; Thevenin D; Suberville AM
    Leukemia; 1987 Feb; 1(2):121-6. PubMed ID: 3478535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: clinical correlations in acute nonlymphocytic leukemia.
    Park CH; Amare M; Morrison FS; Maloney TR; Goodwin JW
    Cancer Treat Rep; 1982 Jun; 66(6):1257-61. PubMed ID: 7083232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CFU-gm colony formation of peripheral blood and bone marrow in adult acute leukemia at presentation, during remission, and at relapse.
    Jehn U; Wachholz K
    Int J Cell Cloning; 1985 Jul; 3(4):199-213. PubMed ID: 3860564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

  • 54. Prediction of response to chemotherapy in acute myelocytic leukemia.
    Preisler HD
    Blood; 1980 Sep; 56(3):361-7. PubMed ID: 6931620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adriamycin in the treatment of acute leukaemia.
    Whitehouse JM; Crowther D; Bateman CJ; Beard ME; Malpas JS
    Br Med J; 1972 Feb; 1(5798):482-3. PubMed ID: 4500405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
    Moriyama Y; Urushiyama M; Hirosawa H; Koyama S; Takai K; Fujiwara M; Kishi K; Takahashi M; Sakai C; Sanada M; Shibata A
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 58. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
    Presant CA; Berger NA; Klahr C; Phillips GL
    Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults.
    Ohno R; Hirano M; Imai K; Koie K; Kamiya T; Nishiwaki H; Ishiguro J; Uetani T; Sako F; Imamura K
    Cancer; 1975 Dec; 36(6):1945-9. PubMed ID: 1060503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between growth in agar, karyotype and prognosis in acute leukaemia.
    Gustavsson A; Mitelman F; Olofsson T; Olsson I
    Scand J Haematol; 1984 Apr; 32(4):351-63. PubMed ID: 6585926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.